Indeed, both treatments with STING agonist and 2’3-cGAMP can induce CXCL10 production and block cell proliferation specifically in Notch2-mutated but not in Notch1-mutated or Notch-wt SCLC [74]. This evidence concerns the gene STING1 and small cell lung carcinoma.